Amita

Gupta

,

MD

Dr. Gupta is the Florence Sabin Professor of Infectious Diseases and Director of the Division of Infectious Diseases at the Johns Hopkins School of Medicine, and she holds a joint appointment in the Department of International Health at the JH Bloomberg School of Public Health. She is board-certified in infectious diseases and is a practicing physician at Johns Hopkins Hospital. 

Dr. Gupta’s work focuses on international clinical research, public health, and education in infectious diseases, with specialties in HIV/AIDS, tuberculosis (TB), and antimicrobial resistant infections. Since 2003, her research has focused primarily on India, where she leads several JHU research collaborations. She has been awarded research grants from the NIH, CDC, UNITAID, and several philanthropic foundations to investigate infectious diseases of importance to India and beyond. She is a faculty member of the Center for Infectious Diseases in India, and is the founder and Faculty Steering Committee Co-chair of the Gupta-Klinsky India Institute (GKII). GKII brings together more than 165 faculty from across 7 Johns Hopkins University schools to collaborate with Indian institutions on research, programs, and policies that serve Indo-US national and global interests.   

She is an active clinical investigator in multi-country trials conducted by the Advancing Clinical Therapeutics Globally (ACTG) network and the International Maternal Pediatric Adolescent AIDS Trials network (IMPAACT), and she has served as protocol chair for high impact TB prevention studies that have resulted in publications in The New England Journal of Medicine and The Lancet.  

Dr. Gupta’s other scientific leadership positions include serving Vice-Chair for the IMPAACT TB Scientific Committee. She is US Chair for the Indo-US Vaccine Action Program-sponsored RePORT India TB research consortium, which is funded by the US National Institutes of Health (NIH) and the government of India, Department of Biotechnology since 2013. She also is a member of the global RePORT International Executive Committee, a multilateral global consortia for TB research, and Co-principal Investigator of the NIH-funded Johns Hopkins University Baltimore-India Clinical Trials Unit (JHUBI-CTU). She previously served on the Johns Hopkins Precision Medicine Center for Excellence for COVID-19, and in 2019, Dr. Gupta was appointed by the US Health and Human Services Secretary for a 4-year term to the NIAID Council, the chief advisory committee for National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health. In 2020, she was invited to the Governing Board of the Indo-U.S. Science & Technology Forum, and in 2023 was appointed to serve on the Association of American Universities’ Task Force on Expanding United States-India Partnerships. She is a Founder’s Circle member of Indiaspora. 

Dr. Gupta is an author of more than 250 peer-reviewed research publications and 7 book chapters on prevention and treatment of HIV, TB, and other infectious diseases, primarily in low- and middle-income settings. She has mentored more than 40 junior scientists in India and the US to run research studies and submit their own scientific findings to peer-reviewed publications. 

Dr. Gupta received an undergraduate degree from Massachusetts Institute of Technology (MIT) in Materials Science Engineering, a Doctor of Medicine from Harvard Medical School, and a Master of Health Sciences in clinical investigation from Johns Hopkins Bloomberg School of Public Health. She completed her internal medicine training at San Francisco General Hospital-University of California, San Francisco, followed by post-doctoral fellowships with the Epidemic Intelligence Service at the US Centers for Disease Control and Prevention (CDC, Foodborne and Diarrheal Diseases) and at the Johns Hopkins School of Medicine (Infectious Diseases).